Infectious Diseases (except HIV/AIDS)

Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent Children

1. Madeleine D. Burns
2. Brittany P. Boribong
3. Yannic C. Bartsch
4. Maggie Loiselle
5. Kerri J. St. Denis
6. Maegan L. Sheehan
7. Jessica W. Chen
8. Jameson P. Davis
9. Rosiane Lima
10. Andrea G. Edlow
11. Alessio Fasano
12. Alejandro B. Balazs
13. Galit Alter
14. Lael M. Yonker

Reviewed by ScreenIT

Reconstruction of transmission chains of SARS-CoV-2 amidst multiple outbreaks in a geriatric acute-care hospital: a combined retrospective epidemiological and genomic study

1. Mohamed Abbas
2. Anne Cori
3. Samuel Cordey
4. Florian Laubscher
5. Tomás Robalo Nunes
6. Ashleigh Myall
7. Julien Salamun
8. Philippe Huber
9. Dina Zekry
10. Virginie Prendki
11. Anne Iten
12. Laure Vieux
13. Valérie Sauvan
14. Christophe E Graf
15. Stephan Harbarth

• Curated by eLife

  Evaluation Summary:

  This paper by Dr. Abbas and colleagues uses genomic and epidemiological methods to track SARS-CoV-2 spread in a healthcare facility. It demonstrates that genomic data can be used to track the spread of viruses in healthcare environments and documents that inter-ward transmission is important in healthcare settings. Overall, the conclusions are supported by the data and analysis and the paper demonstrates that genomics may be an important adjunct tool for tracking the nosocomial transmission of respiratory viruses.

  (This preprint has been reviewed by eLife. We include the public reviews from the reviewers here; the authors also receive private feedback with suggested changes to the manuscript. Reviewer #1 and Reviewer #3 agreed to share their names with the authors.)

Reviewed by eLife, ScreenIT

Comparison of SARS-CoV-2 Reverse Transcriptase Polymerase Chain Reaction and BinaxNOW Rapid Antigen Tests at a Community Site During an Omicron Surge

1. John Schrom
2. Carina Marquez
3. Genay Pilarowski
4. Chung-Yu Wang
5. Anthea Mitchell
6. Robert Puccinelli
7. Doug Black
8. Susana Rojas
9. Salustiano Ribeiro
10. Valerie Tulier-Laiwa
11. Jacqueline Martinez
12. Joselin Payan
13. Susy Rojas
14. Diane Jones
15. Daniel Martinez
16. Robert Nakamura
17. Gabriel Chamie
18. Vivek Jain
19. Maya Petersen
20. Joe DeRisi
21. Diane Havlir

Reviewed by ScreenIT

A Method for Variant Agnostic Detection of SARS-CoV-2, Rapid Monitoring of Circulating Variants, and Early Detection of Emergent Variants Such as Omicron

1. Eric Lai
2. Emily B. Kennedy
3. Jean Lozach
4. Kathleen Hayashibara
5. Jeremy Davis-Turak
6. David Becker
7. Pius Brzoska
8. Tyler Cassens
9. Evan Diamond
10. Manoj Gandhi
11. Alexander L. Greninger
12. Pooneh Hajian
13. Nicole A. Leonetti
14. Jason M. Nguyen
15. K. M. Clair O’Donovan
16. Troy Peck
17. Jimmy M. Ramirez
18. Pavitra Roychoudhury
19. Efren Sandoval
20. Cassandra Wesselman
21. Timothy Wesselman
22. Simon White
23. Stephen Williams
24. David Wong
25. Yufei Yu
26. Richard S. Creager

Reviewed by ScreenIT

SARS-CoV-2 Risk Quantification Model and Validation Based on Large-Scale Dutch Test Events

1. Bas Kolen
2. Laurens Znidarsic
3. Andreas Voss
4. Simon Donders
5. Iris Kamphorst
6. Maarten van Rijn
7. Dimitri Bonthuis
8. Merit Clocquet
9. Maarten Schram
10. Rutger Scharloo
11. Tim Boersma
12. Tim Stobernack
13. Pieter van Gelder

Reviewed by ScreenIT

A Novel Scoring System for Early Assessment of the Risk of the COVID-19-associated Mortality in Hospitalized Patients: COVID-19 BURDEN

1. Fatemeh Amirzadehfard
2. Mohammad Hossein Imanieh
3. Sina Zoghi
4. Faezeh Sehatpour
5. Peyman Jafari
6. Hamidreza Hassanipour
7. Maryam Feili
8. Maryam Mollaie
9. Pardis Bostanian
10. Samrad Mehrabi
11. Reyhaneh Dashtianeh
12. Afrooz Feili

Reviewed by ScreenIT

Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine

1. Yi Ju
2. Wen Shi Lee
3. Emily H. Pilkington
4. Hannah G. Kelly
5. Shiyao Li
6. Kevin J. Selva
7. Kathleen M. Wragg
8. Kanta Subbarao
9. Thi H. O. Nguyen
10. Louise C. Rowntree
11. Lilith F. Allen
12. Katherine Bond
13. Deborah A. Williamson
14. Nghia P. Truong
15. Magdalena Plebanski
16. Katherine Kedzierska
17. Siddhartha Mahanty
18. Amy W. Chung
19. Frank Caruso
20. Adam K. Wheatley
21. Jennifer A. Juno
22. Stephen J. Kent

Reviewed by ScreenIT

Safety and Immunogenicity of the BBIBP-CorV Vaccine in Adolescents Aged 12 to 17 Years in the Thai Population: An Immunobridging Study

1. Kriangkrai Tawinprai
2. Taweegrit Siripongboonsitti
3. Thachanun Porntharukchareon
4. Preeda Vanichsetakul
5. Saraiorn Thonginnetra
6. Krongkwan Niemsorn
7. Pathariya Promsena
8. Manunya Tandhansakul
9. Naruporn Kasemlawan
10. Natthanan Ruangkijpaisal
11. Narin Banomyong
12. Nanthida Phattraprayoon
13. Teerapat Ungtrakul
14. Kasiruck Wittayasak
15. Nawarat Thonwirak
16. Kamonwan Soonklang
17. Gaidganok Sornsamdang
18. Nithi Mahanonda

Reviewed by ScreenIT

Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19

1. Lyn R. Frumkin
2. Michaela Lucas
3. Curtis L. Scribner
4. Nastassja Ortega-Heinly
5. Jayden Rogers
6. Gang Yin
7. Trevor J. Hallam
8. Alice Yam
9. Kristin Bedard
10. Rebecca Begley
11. Courtney A. Cohen
12. Catherine V. Badger
13. Shawn A. Abbasi
14. John M. Dye
15. Brian McMillan
16. Michael Wallach
17. Traci L. Bricker
18. Astha Joshi
19. Adrianus C. M. Boon
20. Suman Pokhrel
21. Benjamin R. Kraemer
22. Lucia Lee
23. Stephen Kargotich
24. Mahima Agochiya
25. Tom St. John
26. Daria Mochly-Rosen

Reviewed by ScreenIT

The dynamics of SARS-CoV-2 infectivity with changes in aerosol microenvironment

1. Henry P. Oswin
2. Allen E. Haddrell
3. Mara Otero-Fernandez
4. Jamie F. S. Mann
5. Tristan A. Cogan
6. Thomas G. Hilditch
7. Jianghan Tian
8. Daniel A. Hardy
9. Darryl J. Hill
10. Adam Finn
11. Andrew D. Davidson
12. Jonathan P. Reid

Reviewed by ScreenIT